Citing her leadership in advancing extremely complex biomedical research, the Arizona Bioindustry Association today announced that Lynn Hudson, Ph.D., Chief Science Officer for the Critical Path Institute, will be honored with the Jon W. McGarity Arizona Bioscience Leader of the Year Award, during ceremonies later this year.Continue reading→

Gold Award recognizes the FDA approval of a study into the effectiveness of the SynCardia Total Artificial Heart powered by the Freedom® portable driver for end-stage biventricular heart failure patients who don’t qualify for donor heart transplants.Continue reading→

“SynCardia Systems, a developer and manufacturer of temporary implantable artificial hearts, filed on Monday with the SEC to raise up to $40 million in an initial public offering.”  (Source) Continue reading→

Blackstone Ventures Inc.  (TSX VENTURE:BLV)  has entered into a letter of intent, subject to receipt of all applicable regulatory and shareholder approvals, to acquire Lattice Biologics Inc.Continue reading→

SCIENCE FOUNDATION ARIZONA, INTEL ANNOUNCE CODE WRITERS EDUCATION INITIATIVE

Continue reading→

Rapid, accurate test for coccidioidomycosis developed by TGen’s Pathogen Genomics Division to accelerate patient careContinue reading→

PHOENIX — A multicenter study involving Mayo Clinic researchers has found that the National Cancer Institute’s Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), was accurate, reliable and responsive, compared to other, established patient-reported and clinical measures. The study is published today in the journal JAMA Oncology.Continue reading→

University of Arizona Cancer Center at St. Joseph’s Hospital Set To OpenContinue reading→

New technology addresses the most common global cause of bacterial food-borne illness Continue reading→